Concepedia

Publication | Closed Access

Preparation of an anhydrous reverse micelle delivery system to enhance oral bioavailability and anti-diabetic efficacy of berberine

DOI

93

Citations

26

References

2011

Year

Ting Wang, Ning Wang, Hui Song, Xiaonan Xi, Jianan Wang, Aijun Hao, Tiefu Li
European Journal of Pharmaceutical Sciences

References

YearCitations

Guide for the care and use of laboratory animals

Choice Reviews Online

1997

2.9K

Applied Biopharmaceutics and Pharmacokinetics.

Annals of Internal Medicine

1981

1.2K

Efficacy of berberine in patients with type 2 diabetes mellitus

Jun Yin, Xing Hui-li, Jianping Ye

Metabolism

2008

743

Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine

Yifei Zhang, Dajin Zou, Wei Liu,

The Journal of Clinical Endocrinology & Metabolism

2008

555

Streptozotocin‐Induced Diabetic Models in Mice and Rats

Kenneth K. Wu, Youming Huan

Current Protocols in Pharmacology

2008

374

Pharmacokinetics of Berberine and Its Main Metabolites in Conventional and Pseudo Germ-Free Rats Determined by Liquid Chromatography/Ion Trap Mass Spectrometry

Feng Zuo, Norio Nakamura, Teruaki Akao,

Drug Metabolism and Disposition

2006

274

Acute toxicity of berberine and its correlation with the blood concentration in mice

Michael M. Kheir, Yugang Wang, Lei Hua,

Food and Chemical Toxicology

2010

229

Berberine Differentially Modulates the Activities of ERK, p38 MAPK, and JNK to Suppress Th17 and Th1 T Cell Differentiation in Type 1 Diabetic Mice

Guoliang Cui, Xia Qin, Yuebo Zhang,

Journal of Biological Chemistry

2009

198

Berberine stimulates glucose transport through a mechanism distinct from insulin

Libin Zhou, Ying Yang, Xiao Wang,

Metabolism

2007

187

Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine

Ihab M. Almasri, Mohammad K. Mohammad, Mutasem O. Taha

Journal of Enzyme Inhibition and Medicinal Chemistry

2009

150

Page 1